Xenon Pharmaceuticals Inc. XENE

Set alert

39.17 USD +1.49 (+3.95%)

At closeNov 6, 2026, 5:56 PM EST

39.39 +0.22 +0.56%

After hours · Nov 6, 5:56 PM ET

37.15 Day range 39.20

33.38 52-week range 72.66

Held by insiders 0.17%

Held by institutions 108.15%

Float held by institutions 108.33%

Institutions 438

Top institutional holders
Holder	% held	Shares	Value	Reported
FMR, LLC	9.98%	9,647,998	377.91M	Jun 29, 2026
Blackrock Inc.	7.78%	7,522,482	294.66M	Jun 29, 2026
Avoro Capital Advisors LLC	5.98%	5,777,777	226.32M	Jun 29, 2026
Polar Capital Holdings PLC	4.73%	4,570,556	179.03M	Jun 29, 2026
Driehaus Capital Management, LLC	4.57%	4,418,557	173.07M	Jun 29, 2026
Jupiter Topco LLC	4.33%	4,186,519	163.99M	Jun 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total	3.71%	3,583,633	140.37M	Sep 29, 2026
SmallCap World Fund Inc	2.91%	2,814,992	110.26M	Sep 29, 2026
iShares Trust-iShares Russell 2000 ETF	2.63%	2,537,750	99.40M	Sep 29, 2026
T. ROWE PRICE CAPITAL APPRECIATION Fd., INC.-T. Rowe Price Capital App	1.32%	1,274,673	49.93M	Jun 29, 2026
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund	1.11%	1,074,458	42.09M	Aug 30, 2026
JPMorgan Trust II-JPMorgan Mid Cap Growth Fund	1.00%	962,101	37.69M	Jun 29, 2026

XENE insiders
Insider	Relation	Latest transaction	Date	Shares held
CANNON GILLIAN	Director	Sale	Jun 4, 2026	1,455
DIFABIO ANDREA	Officer	Sale	Mar 12, 2026	7,301
GANNON STEVEN	Director	Sale	Aug 10, 2026	1,870
GAROFALO ELIZABETH AMY M.D.	Director	Conversion of Exercise of derivative security	May 31, 2026	2,645
GOVER JUSTIN DAVID	Director	Conversion of Exercise of derivative security	May 31, 2026	2,645
KELLY THOMAS PATRICK	Chief Financial Officer	Purchase	Sep 29, 2026	15,000

Held by funds